Berrino, F, R. De Angelis, M. Sant, et al. Survival
for eight major cancers and all cancers combined
for European adults diagnosed in 1995-99: results
of EUROCARE-4 study.- Lancet Oncol., 8, 2007, No
, 773-783.
Cancer incidence in Bulgaria 2010. Vol. 21. Sofia,
National Oncological Hospital, 2012.
Ceelen, W. P. Progress in rectal cancer treatment.-
ISRN Gastroenterol., 2012; 2012: 648183. doi:
5402/2012/648183.
Cheng, L., C. Eng, L. Z. Nieman, et al. Trends in
colorectal cancer incidence by anatomic site and
disease stage in the United States from 1976 to
- Am. J. Clin. Oncol., 34, 2011, No 6, 573-80.
Ferlay, J., D.M. Parkin, E. Steliarova-Foucher.
Estimates of cancer incidence and mortality in
Europe in 2008.- Eur. J. Cancer, 46, 2010, No 4,
-781.
Gérard, J. P., A. S. Myint, O. Croce, et al.
Renaissance of contact x-ray therapy for treating
rectal cancer.- Expert Rev. Med. Devices, 8, 2011,
No 4, 483-492.
Kim, T. W., J. H. Lee, J. H. Ahn, et al. Randomized
trial of postoperative adjuvant therapy in stage II
and III rectal cancer to define the optimal sequence
of chemotherapy and radiotherapy: 10-year followup.-
Int. J. Radiat. Oncol. Biol. Phys., 81, 2011, No 4,
-1031.
NCCN. Rectal cancer. Vol. 4. 2013.
Salerno, G., I. R. Daniels, B. J. Moran, et al.
Clarifying margins in the multidisciplinary
management of rectal cancer: the MERCURY
experience.- Clin. Radiol., 61, 2006, No 11, 916-923.
Schmoll, H. J., E. Van Cutsem, A. Stein, et al.
ESMO Consensus Guidelines for management
of patients with colon and rectal cancer: a
personalized approach to clinical decision making.-
Ann. Oncol., 23, 2012, No 10, 2479-2516.
Sun Myint, A., R. J. Grieve, A. C. McDonald, et
al. Combined modality treatment for early rectal
cancer. The UK experience.- Clin. Oncol., 19, 2007,
No 9, 674-681.
Valentini, V., R. Beets-Tan, J. M. Borras, et al.
Evidence and research in rectal cancer.- Radiother.
Oncol., 87, 2008, No 3, 449-474.
Valentini, V., C. Aristei, B. Glimelius, et al.;
Scientific Committee. Multidisciplinary Rectal
Cancer Management: 2nd European Rectal
Cancer Consensus Conference (EURECA-CC2).-
Radiother Oncol., 92, 2009, No 2, 148-163.
Valentini, V., P. Lambin, R. J. Myerson. Is it
time for tailored treatment of rectal cancer?
From prescribing by consensus to prescribing by
numbers.- Radiother. Oncol., 102, 2012, No 1, 1-3.
Email this article (Login required) 
